A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy

NCT02607124 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
11
Enrollment
OTHER
Sponsor class

Stopped A competing trial was opened for patient population with combination of ribociclib and everolimus.

Conditions

Interventions

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators